Jean-Jacques Bienaim
2017
In 2017, Jean-Jacques Bienaim earned a total compensation of $15.9M as Chief Executive Officer at BioMarin Pharmaceutical, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,726,010 |
|---|---|
| Option Awards | $5,253,707 |
| Salary | $1,094,423 |
| Stock Awards | $7,783,876 |
| Other | $58,969 |
| Total | $15,916,985 |
Bienaim received $7.8M in stock awards, accounting for 49% of the total pay in 2017.
Bienaim also received $1.7M in non-equity incentive plan, $5.3M in option awards, $1.1M in salary and $59K in other compensation.
Rankings
In 2017, Jean-Jacques Bienaim's compensation ranked 248th out of 14,666 executives tracked by ExecPay. In other words, Bienaim earned more than 98.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 248 out of 14,666 | 98th |
Division Manufacturing | 72 out of 5,772 | 99th |
Major group Chemicals And Allied Products | 19 out of 2,075 | 99th |
Industry group Drugs | 14 out of 1,731 | 99th |
Industry Pharmaceutical Preparations | 13 out of 1,333 | 99th |
Source: SEC filing on April 23, 2019.
Bienaim's colleagues
We found four more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2017.
2017
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2017
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2017
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
2017
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019